摘要
As the predominant pathway for the repair of DNA double-strand breaks (DSB), non-homologous end joining (NHEJ) attenuates the efficacy of cancer treatment which relies on the introduction of DSBs, such as radiotherapy and genotoxic drugs. Identifying novel NHEJ inhibitors is of great importance for improving the therapeutic efficiency of radio- or chemotherapy. Here we miniaturized our recently developed NHEJ detecting system into a 96-well plate-based format and interrogated an FDA approved drug library containing 1732 compounds. A collection of novel hits were considered to be potential DSB repair inhibitors at the noncytotoxic concentration. We identified omipalisib as an efficient sensitizer for DNA damage-induced cell death in vitro. Furthermore, in vitro analysis uncovered the repressive effect of omipalisib on the phosphorylation of DNA-dependent protein kinase catalytic subunit induced by ionizing radiation and doxorubicin, which led to the suppression of NHEJ pathway.
学科与关键词
- A NOVEL INHIBITOR OF NHEJ, ONE OF THE DNA DOUBLE-STRAND BREAK REPAIR PATHWAYS, CAN ENHANCE THE EFFICACY OF RADIO AND CHEMOTHERAPY-A MILESTONE IN CANCER TREATMENTSathees C.Raghavan第三届亚洲辐射研究大会, 北京, 2013.
- Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) InhibitorsKasun, Wanigasooriya; Robert, Tyler; Joao D., Barros-Silva; Yashashwi, Sinha; Tariq, Ismail; Andrew D., BeggsCancers, 2020, 12(5): 1278.被引 7
- A Common Chk1-Dependent Phenotype of DNA Double-Strand Break Suppression in Two Distinct Radioresistant Cancer TypesDinkelborg P. H.; Wang M.; Gheorghiu L.; Hong T. S.; Jimenez R. B.; Grossmann P.; Dejan J.; Gurski J. M.; Benes C.; Borgmann K.; Willers H.60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2018-10-21 To 2018-10-24.
